baber/WOPTO huggingface dataset:
Patent JP-2739725-B2 (JP)
IPC: A61M21/00
Filed: 1988-06-27
Granted: 1998-04-15
Abstract: A method for accurately assessing and rapidly modifying the phase and amplitude of the endogenous circadian pacemaker is disclosed. A circadian cycle modification capacity assessment method comprises (before and after a stimulus) eliminating activity-related confounding factors associated with the sleep-rest cycle which otherwise mask the state of the endogenous circadian pacemaker. Based on either individual or normative assessment data, the circadian phase and amplitude modification method involves the application of bright (about 9,500 lux) light and, advantageously, episodes of imposed darkness, at critically chosen phases to achieve rapid and stable changes in phase and amplitude. The timing of the episodes of bright light may be chosen either by reference to empirically-derived phase response data, or by using a mathematical model in which the endogenous circadian pacemaker is a van der Pol oscillator. A forcing function in the model is substantially proportional to changes in the cube root of the surrounding illuminance, in lux. The amplitude of the endogenous circadian pacemaker may actually be reduced to substantially zero, so as to bring about dramatic phase modifications in diminishingly small periods of time. The methods find special utility in treating "jet lag" sufferers, shift workers, advanced circadian phase experienced by many elderly subjects, and those afflicted with delayed sleep phase insomnia.
Patent JP-2862673-B2 (JP)
IPC: C03B5/02
Filed: 1991-04-17
Granted: 1999-03-03
Abstract: A waste vitrification apparatus ( 10 ) having rotatable mixer impeller ( 16 ) functioning as a shaft electrode ( 60 ) and metallic vessel ( 14 ) functioning as a vessel electrode ( 62 ). A stream ( 12 ) of waste material and vitrifiable material are mixed and melted in the vessel ( 14 ) for vitrification. The waste vitrification method converts a feed stream ( 12 ) by mixing the feed stream into a glass melt ( 13 ) and melting glass batch of the feed stream ( 12 ) to form a foamy mass. The stream is dispersed by the impeller ( 16 ) to form a foam which is then densified in a settling zone ( 22 ), recovered through a spout ( 24 ) and solidified in storage containers. Means are provided to adjust the location of the mixing impeller ( 16 ) in the vessel ( 14 ) to change the depth of the settling zone ( 22 ). The impeller ( 16 ) is mounted on a drive shaft ( 18 ) having a recirculating coolant flow.
Patent JP-3132002-B2 (JP)
IPC: C07H17/08
Filed: 1992-12-25
Granted: 2001-02-05
Abstract: A 3-(substituted carbonyloxy)-5-O-desosaminylerythronolide derivative represented by general formula (I), which is useful as a novel macrolide antibiotic with a potent antibacterial power, wherein R' and R'' represent each hydrogen or acyl; Y represents optionally substituted alkylene, ether linkage, acid linkage or vinylene; R represents hydrogen, optionally substituted alkyl, aryl or heteroaryl; and -A- represents an erythronolide moiety (wherein the 9-position may be an imino ether group and the 11- and 12-positions may be involved in the formation of a heterocycle such as a cyclic carbonate group) or a 9-azahomoerythronolide moiety. <CHEM>
Patent JP-2977903-B2 (JP)
IPC: A01N63/23
Filed: 1993-12-13
Granted: 1999-11-15
Abstract: The invention is related to a biologically pure Bacillus thuringiensis (B.t.)strain active against lepidopteran and coleopteran pests which produces a bipyramidal crystal consisting essentially of a delta-endotoxin having a molecular weight of about 130,000 daltons and a rhomboidal crystal consisting essentially of two delta-endotoxins, each having a molecular weight of about 33,000 daltons, as well as spores, crystals, delta-endotoxins and/or mutants thereof. The invention also relates to insecticidal compositions obstainable therefrom. The invention further relates to methods of using the insecticidal compositions to control insect pest from the order Lepidoptera and/or Coleoptera. The invention also relates to isolated DNA sequences encoding the delta-endotoxins. <IMAGE>
Patent JP-3450861-B2 (JP)
IPC: C08G65/28
Filed: 1997-12-22
Granted: 2003-09-29
Abstract: The invention concerns polyalcoxylated terpenic compounds of formula Z-X-W-[CH(R<5>)-CH(R<6>)-O]q-A in which Z is a bicycloheptenyl or bicycloheptyl radical, preferably substituted by methyl radicals; X is preferably a -CH2-CH2-O or -O-CH2-CH2-O- radical; W is a polysequence, preferably polyoxypropylene and polyoxyethylene; [CH(R<5>)-CH(R<6>)-O]q is a sequence different from a polyoxyethylene sequence, preferably polyoxypropylene; A is H, a functional or hydrocarbon group. They can be prepared by successively polyalcoxylating the reagent Z-XH. They can be used as antifoaming agents in foaming aqueous media, in particular in degreasing aqueous media in alkaline medium of sheet metals, as well as detergent aqueous media in household washing or industrial and institutional washing.
Patent JP-3241376-B2 (JP)
IPC: C07H1/06
Filed: 1991-09-05
Granted: 2001-12-25
Abstract: Thin film composite ultrafiltration membrane which possesses desirable properties or characteristics may be prepared by casting a solution of a polyelectrolyte complex on a microporous support to form a thin film of the polyelectrolyte complex on the surface of the supports. The thickness of the polyelectrolyte complex membrane will range from about 600 to about 3,000  ANGSTROM . This membrane may then be used for the separation of low molecular weight solutes such as, for example, the separation of glucose from sucrose and higher molecular weight sugars.
Patent JP-3249116-B2 (JP)
IPC: B26B21/00
Filed: 1991-07-24
Granted: 2002-01-21
Abstract: A shaving system that includes a holder and a blade member secured to the holder. The blade member has an aperture that defines an annular sharpened edge with main facet portions that converge at an angle of less than 30 degrees and supplemental facet portions that are extensions of the main facet portions and define an ultimate tip defining portion that has an included angle of less than 30 degrees. The supplemental facet portions are offset in the same direction from the main facet portions each at an angle of less than 175 degrees, the outer main facet portion defines a shaving plane, the ultimate tip is disposed above the shaving plane less than 0.1 millimeter, and the bisector of the included angle defined by the supplementary facets is disposed at an angle to the shaving plane in the range of 15 degrees-35 degrees.
Patent JP-2599328-B2 (JP)
IPC: H04W84/08
Filed: 1991-09-03
Granted: 1997-04-09
Abstract: A communication system (100) is provided comprising a communication resource controller (110) wherein the likelihood of success for establishing synchronous digital communication with a communication unit (120) is substantially greater than the likelihood of success for establishing analog communication. The communication unit may establish analog communication after the communication resource controller receives a digital access code from the communication unit. The analog communication is deferred until the received signal strength from the communication resource controller is above a predetermined level which makes the establishment of analog communication substantially likely.
Patent JP-3479079-B2 (JP)
IPC: D06M13/322
Filed: 1995-04-12
Granted: 2003-12-15
Abstract: PCT No. PCT/GB95/00838 Sec. 371 Date Sep. 9, 1996 Sec. 102(e) Date Sep. 9, 1996 PCT Filed Apr. 12, 1995 PCT Pub. No. WO95/28516 PCT Pub. Date Oct. 26, 1995The present invention relates to a method for reducing the fibrillation tendency of lyocell fibre. Never-dried fibre is treated by an inorganic alkali solution and a chemical reagent having an average of greater than 2.1 acrylamido groups, and then heated. This method produces cellulose materials with a smooth white appearance resistant to creasing in the wet state.
Patent JP-3669706-B2 (JP)
IPC: G01N29/14
Filed: 1996-02-20
Granted: 2005-07-13
Abstract: A method and apparatus for the inspection of ferromagnetic and non-ferromagnetic pipes, tubes or other cylindrical shell structures utilizing the magnetostrictive effect to detect defects such as corrosion pits, wall thinning, and cracks within the structure under evaluation. The apparatus and method constitute an active testing application, wherein 1) a transmitting coil element generates a mechanical pulse within a cylindrical shell structure through the magnetostrictive effect and a second coil detects reflected mechanical waves within the pipe, this by the inverse magnetostrictive effect, or 2) a single sensor functions as both transmitter and detector. The present invention also anticipates a passive monitoring application with a detection coil that continuously monitors ferromagnetic or non-ferromagnetic tubes, pipes, etc., for mechanical or acoustic wave emissions and either records this monitored information or alerts the appropriate personnel to the existence of mechanical or acoustic wave emissions indicative of deterioration. Non-ferromagnetic pipes, tubes, etc., are made amenable to inspection by attaching a layer of ferromagnetic material such as nickel on either the inner or outer walls of the pipes, tubes, etc. by plating or bonding such material in a local area where the sensor is to be placed.
Patent JP-3067806-B2 (JP)
IPC: A61P23/00
Filed: 1995-03-17
Granted: 2000-07-24
Abstract: Sterile pharmaceutical compsn. for parenteral admin. is an oil-in-water emulsion in which propofol (I) (2,6-diisopropylphenol), opt. dissolved in a water-immiscible solvent, is emulsified with water and stabilised by surfactant. It also includes enough EDTA or salt to prevent growth of microorganisms for at least 24 hr after accidental contamination. Also new are similar emulsions that do not contain (I) but may contain some other therapeutic or pharmaceutical agent (II), opt. dissolved in organic solvent.
Patent JP-4332220-B2 (JP)
IPC: B01D39/20
Filed: 1996-12-13
Granted: 2009-09-16
Abstract: A method for forming dendritic metal powders, comprising the steps of: (1) heating a powder comprising non-dendritic particles, under conditions suitable for initial stage sintering, to form a lightly sintered material; and (2) breaking the lightly sintered material to form a powder comprising dendritic particles. In one embodiment, the lightly sintered material is broken by brushing the material through a screen. Another aspect of the present invention comprises the dendritic particles that are produced by the method described above. These particles can comprise any suitable metal, such as transition metals, rare earth metals, main group metals or metalloids or an alloy of two or more such metals. The particles can also comprise a ceramic material, such as a metal oxide. These particles are characterized by a dendritic, highly anisotropic, morphology arising from the fusion of substantially non-dendritic particles, and by a low apparent density relative to the substantially non-dendritic starting material. The present dendritic particles can be of high purity, and substantially free of carbon contamination.
Patent ES-2173039-B2 (ES)
Title: Mejoras introducidas en los sistemas de encofrado.
Inventor: JORGE HOUCHE DANIEL
IPC: E04C3/07
Filed: 2000-11-24
Granted: 2004-08-01
Abstract: Mejoras introducidas en los sistemas de encofrado. El sistema de encofrado según las mejoras consiste en utilizar las sopandas (1) dotadas de parejas de perfiles (6) con laterales de rigidización de los mismos, para posicionado de las sopandas extremas (2) e intermedias (3), contando aquellas con una configuración tubular especial de gran amplitud como superficies de apoyo superiores (10) para los correspondientes tableros de encofrado (4), complementándose con soportes (5) dispuestos entre esos tableros (4). Tanto las porta-sopandas (1) como las sopandas extremas (2), intermedias (3) y soportes (5), incorporan en sus extremos correspondientes tapas (17) que impiden la entrada de humedad y rigidizan dichos extremos ante posibles caídas en el desencofrado.
Patent ES-2284384-B2 (ES)
Title: Mejoras introducidas en la patente de invencion p200502619 por "tejido anti-perforacion".
Inventor: MORON RUBIO JOSE ANTONIO
IPC: A43B7/32
Filed: 2006-03-21
Granted: 2009-06-22
Abstract: Mejoras introducidas en la patente de invención
nº  P 200502619 por: "Tejidos
anti-perforación". 
     Las mejoras consisten en sustituir el poliéster
por poliamida, de manera que partiendo de la solución básica de la 
patente principal en la que se utilizaban exclusivamente capas de
tejido de poliéster unidas entre sí mediante capas de  látex, EVA o
poliuretano, ahora parte de dichas capas de poliéster pueden ser
sustituidas por capas de tejido de   poliamida, en cualquier
proporción, o bien una misma capa de tejido puede estar obtenida
mediante una combinación  de hilos de poliéster e hilos de
poliamida, también con cualquier proporción, e incluso la mezcla de
poliéster y   poliamida, en cualquier proporción, puede constituir
la materia prima para la formación de los hilos con los que se tejen
las distintas capas.
Patent ES-2329535-B2 (ES)
Title: Dispositivo y sistema para disminuir la fase aerea en las estructuras de edificacion.
Inventor: CASTILLO GUILLEN VICENTE
IPC: E04B1/343
Filed: 2006-11-10
Granted: 2010-08-24
Abstract: Dispositivo y sistema para disminuir la fase
aérea en las estructuras de  edificación. 
     Un sistema para la construcción de estructuras
de edificación formado por  soportes telescópicos unidos a
estructuras horizontales tales como forjados  de piso en cada uno de
sus segmentos de modo que estos son elevados por  la acción de unos
equipos de presión hasta su posición definitiva conectados  mediante
tomas de presión.
Patent ES-2398276-B2 (ES)
Title: Cápsula para elaboración de bebida
Inventor: FLORES ARNAIZ JESÚS GUILLERMO
IPC: A47J31/36
Filed: 2012-08-28
Granted: 2014-09-29
Abstract: Cápsula para elaboración de bebida, que comprende una tapa (8) a través de la que se inyecta un fluido a presión a una primera cámara (10) que contiene un producto alimenticio. El fondo de dicha primera cámara (10) comprende unas perforaciones (12) que permiten el paso del fluido mezclado con el producto alimenticio a una segunda cámara (11). La segunda cámara (11) está dotada de tabiques (9) a modo de laberinto para ralentizar la salida de la mezcla del fluido con el producto alimenticio. Una placa (6) constituye el fondo de la primera cámara (10), y está dotada de las perforaciones (12) de paso del fluido mezclado con el producto alimenticio. Los tabiques (9) están dispuestos en la cara inferior de la placa (6), obteniendo un conjunto monopieza de la placa (6) con los tabiques (9).
Patent ES-2543849-B2 (ES)
Title: Indolizinas con propiedades de tinte y procedimiento de síntesis de dichas indolizinas
Inventor: ALONSO VALDES FRANCISCO
IPC: C09B67/44
Filed: 2013-12-23
Granted: 2016-01-18
Abstract: Indolizinas con propiedades de tinte y procedimiento de síntesis de dichas indolizinas.#Se ha descubierto un procedimiento muy novedoso de transformación de indolizinas 1,3-disustituidas en indolizinas 1,3,7-trisustituidas de mayor complejidad estructural que, por su elevada conjugación, absorben radiación en el espectro visible. El tipo de indolizina obtenido es nuevo estructuralmente, presenta coloración naranja rojiza en estado sólido, muestra efecto solvatocrómico y se obtiene selectivamente con buenos rendimientos. La principal particularidad de esta metodología es que los productos se preparan por transformación de un único material de partida, la indolizina, el cual crece estructuralmente a partir de sí mismo mediante un tratamiento ácido/base. Además, el hecho de que se trate de estructuras moleculares nuevas y estas sean solvatocrómicas, deja abierta la posibilidad de estudio de potenciales aplicaciones.
Patent AU-2001251565-B2 (AU)
Title: Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
Inventor: CHRISTIAN SAMUEL T
IPC: C07H17/00
Filed: 2001-04-12
Granted: 2006-09-28
Abstract: Hydrophilic transportable N-linked glycosyl dopaminergic prodrug compounds according to FORMULA V,wherein, Ring 1 comprises a cyclic or heterocyclic ring, or aryl or heteroaryl ring, all of said rings comprising 4 to 8 carbon atoms, among which atoms are counted "X" and "Y"; R0, R1, R2, R3 and R4 comprise substituents of Ring 1; either of X or Y is optional; each of X and Y, when present comprise a carbon atom, a halogen atom or a lower alkyl; Z, R5 and R5' are optional; when Z is present it comprises a lower alkyl having substituents R5, R5'; R6 and R6' comprise substituents on a carbon atom linking Z with N through a single bond, or when Z is absent, linking N with Ring 1; N comprises a nitrogen atom of an amine or an amide linked with E through a single bond and having R7 as a substituent; and E comprises a saccharide.
Patent AU-2001286471-B2 (AU)
Title: Compounds having activity as inhibitors of cytochrome P450RAI
Inventor: WANG LIMING
IPC: A61K31/216
Filed: 2001-08-14
Granted: 2006-09-07
Abstract: Compounds having the Formulas 1 through 8, wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids.
Patent AU-2002210630-B2 (AU)
Title: Method for managing ground assistance teams of locomotive vehicles and data transmission system therefor
Inventor: WEISS FRANCIS
IPC: G06Q10/06
Filed: 2001-10-10
Granted: 2005-12-15
Abstract: The invention concerns a method for managing ground assistance teams of a transport vehicle in a parking zone (19), wherein a management center (3) determines the tasks for the respective assistance teams and provides each team with data specifying its task, comprising the following steps: the management center (3) transmits task data over a radiotelephone network (10); the teams receive the respective data over terminals (15, 16) of the network, which presents the data to them; and after executing the tasks, the teams transmit back to the center (3), from the terminals (15, 16) task performance reports.
Patent AU-2002240702-B2 (AU)
Title: Improved non-reusable syringe
Inventor: INGRAM BRUCE WALLACE
IPC: A61M5/32
Filed: 2002-03-14
Granted: 2004-12-16
Abstract: A single use syringe ( 10 ) has an outer barrel ( 11 ) and an inner barrel ( 12 ) slidable within the outer barrel. The two barrels are initially latched together to prevent relative movement therebetween whereby the syringe is in a useable condition. A needle ( 16 ) is in fluid communication with the inner barrel and projects initially from a first end of the outer barrel. A plunger ( 21 ) in the inner barrel is connected to a plunger actuating rod ( 22 ) which extends out the other end of the outer barrel. On first depression of the plunger actuating rod a limit catch ( 23 ) prevents full depression thereof but allows sufficient depression to draw fluid into the inner barrel. On the second depression the fluid is ejected and the plunger actuating rod and plunger are allowed full travel whereby latching between the two barrels is disengaged. It is not possible to re-latch the barrels together in the useable condition and therefore further use of the syringe is not possible. The needle retracts into the outer barrel after said first use and is locked therein.
Patent AU-2002316673-B2 (AU)
Title: Multi-view imaging apparatus
Inventor: NILSON DAVID
IPC: G01N21/64
Filed: 2002-07-12
Granted: 2007-10-04
Abstract: Systems and methods are provided for taking images of a sample. The sample is placed in an imaging box comprising a moveable stage that allows images of the sample to be taken from various positions and angles within the imaging box. The images are taken by a camera and sent to a processor. Structured light images obtained from one or more views within the imaging box may be used to build a structured light representations of the sample.
Patent AU-2003217970-B2 (AU)
Title: Document processing system including multi-device compatible interface and related methods
Inventor: SHAW GEOFF
IPC: H04L12/56
Filed: 2003-03-06
Granted: 2007-12-20
Abstract: A document processing system may include a document processing device (e.g., a copier), a host (e.g., a computer server), and a multi-device compatible interface for enabling operation of the host and the document processing device from among a plurality of different possible document processing devices. That is, the multi-device compatible interface may determine a set of signals to use with the document processing device upon being connected therewith, and thereafter use the determined set of signals. Accordingly, the multi-device compatible interface may advantageously be used with numerous types of document processing devices despite the differences in their various protocols, connector types, etc.
Patent AU-2003246792-B2 (AU)
Title: Oral suspension of active principle microcapsules
Inventor: CASTAN CATHERINE
IPC: A61K47/30
Filed: 2003-04-07
Granted: 2008-08-28
Abstract: The invention relates to liquid pharmaceutical formulations for oral administration with the modified release of active principle(s), excluding amoxicillin, said formulations consisting of suspensions of coated particles of active principles (microcapsules). According to the invention, the microcapsules constituting the disperse phase of the suspension are designed to allow the modified release of the active principle(s) according to a profile that does not change during the storage of the liquid suspension. To do this the inventors propose the selection of a specific coating composition for the microcapsules which consists of at least four components that allow these microcapsules to be stored in water without modifying their properties of modified release of the active principle, this liquid phase furthermore being saturated with active principle(s).
Patent AU-2003269253-B2 (AU)
Title: Use of the quinazoline derivative ZD6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
Inventor: BARGE ALAN
IPC: A61K31/517
Filed: 2003-10-06
Granted: 2007-04-05
Abstract: The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises the administration of ZD6474 in combination with gemcitabine; to a pharmaceutical composition comprising ZD6474 and gemcitabine; to a combination product comprising ZD6474 and gemcitabine for use in a method of treatment of a human or animal body by therapy; to a kit comprising ZD6474 and gemcitabine; to the use of ZD6474 and gemcitabine in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation.